Market Cap 36.92B
Revenue (ttm) 15.12B
Net Income (ttm) 1.47B
EPS (ttm) N/A
PE Ratio 16.79
Forward PE 16.81
Profit Margin 9.72%
Debt to Equity Ratio 0.67
Volume 18,492,278
Avg Vol 21,132,605
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 4%
Beta 0.47
Analysts Sell
Price Target $19.27

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and bod...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 908 874 1200
Address:
1 Kenvue Way, Summit, United States
Suite510
Suite510 Jul. 15 at 5:01 PM
$JNJ $KVUE JNJ shares fall too, med tech earnings miss and huge Talc and Tylenol legal risks, that’s perfect medicine for them 🤣🙈
1 · Reply
Bazziggr
Bazziggr Jul. 14 at 7:58 PM
$KVUE moved to UTHR
0 · Reply
HydrogenH2
HydrogenH2 Jul. 14 at 3:14 PM
$DJT $KVUE $KMB Federal appeals court revives Tylenol autism lawsuits against Kenvue, overturning prior dismissal Ruling reopens potential for thousands of previously dismissed Tylenol autism cases against Kenvue. Court decision could expose Kenvue to billions of dollars in Tylenol-related autism liability claims.
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Jul. 14 at 3:09 PM
$KVUE back to 15 because of the banana republic legal system they installed.
0 · Reply
topstockalerts
topstockalerts Jul. 13 at 8:30 PM
Kenvue shares fell after Bloomberg reported that a U.S. federal appeals court revived lawsuits alleging the company concealed potential risks that Tylenol use during pregnancy could increase the likelihood of autism and other developmental disorders in children. A three-judge panel in New York ruled that the lower court abused its discretion by excluding testimony from three expert witnesses, sending the cases back for further proceedings, while agreeing that two other experts could remain excluded. The decision reverses a 2023 ruling that had prevented roughly 500 lawsuits from moving forward against Kenvue, the Johnson & Johnson consumer health spin-off. Plaintiffs claim the company failed to warn consumers about the alleged prenatal risks associated with the widely used over-the-counter pain reliever. $KVUE $JNJ
0 · Reply
MandelbrotMarkets
MandelbrotMarkets Jul. 13 at 8:22 PM
$KVUE is facing a new legal overhang. Shares dipped after a federal appeals court revived hundreds of lawsuits alleging Tylenol use during pregnancy may be linked to autism and ADHD risks. The company now faces renewed uncertainty around potential litigation costs and reputational impact. For investors, the key focus will be whether this becomes a material financial liability or remains a manageable legal headline.
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 13 at 8:00 PM
RECAP 7/13 Chatter: $KVUE $KMB - Tylenol Autism suit revived RECAP 7/13 +Pos Comments: $CEPL + BWS Financial $QTTB + Wells Fargo Live Breaking trading news www.openoutcrier.com
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 13 at 5:09 PM
KVUE Stock Dips After Court Revives Tylenol Autism Lawsuits $KVUE $JNJ $VTI $VOO https://stocktwits.com/news/equity/markets/kvue-stock-dips-after-court-revives-tylenol-autism-lawsuits/cZmzDliR7Yj
0 · Reply
LiveSquawk
LiveSquawk Jul. 13 at 3:22 PM
$KVUE | US Appeals Court Revives Lawsuits Against Kenvue; Kenvue Autism Risk Cases Sent Back To Lower Courts For Review
0 · Reply
Noxtradealerts
Noxtradealerts Jul. 13 at 2:31 PM
$0.31 on $KVUE here! 72% return!
0 · Reply
Latest News on KVUE
Kenvue Transcript: AGM 2026

May 21, 2026, 9:00 AM EDT - 7 weeks ago

Kenvue Transcript: AGM 2026


Kenvue Earnings release: Q1 2026

May 7, 2026, 9:30 AM EDT - 2 months ago

Kenvue Earnings release: Q1 2026


Kenvue Quarterly report: Q1 2026

May 7, 2026, 9:30 AM EDT - 2 months ago

Kenvue Quarterly report: Q1 2026


Kenvue Reports First Quarter 2026 Results

May 7, 2026, 6:30 AM EDT - 2 months ago

Kenvue Reports First Quarter 2026 Results

KVUE


Kenvue Declares Quarterly Cash Dividend

Apr 29, 2026, 6:45 AM EDT - 2 months ago

Kenvue Declares Quarterly Cash Dividend

KVUE


Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Apr 23, 2026, 4:32 PM EDT - 2 months ago

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

KVUE


Kenvue Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Kenvue Proxy statement: Proxy filing


Kenvue Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Kenvue Proxy statement: Proxy filing


Tylenol use among women dropped after Trump tied it to autism

Mar 6, 2026, 12:43 PM EST - 4 months ago

Tylenol use among women dropped after Trump tied it to autism

KVUE


Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

Feb 26, 2026, 11:14 AM EST - 4 months ago

Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

KVUE


Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Feb 17, 2026, 5:50 PM EST - 5 months ago

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

KVUE


Kenvue Reports Fourth Quarter and Full Year 2025 Results

Feb 17, 2026, 4:45 PM EST - 5 months ago

Kenvue Reports Fourth Quarter and Full Year 2025 Results

KVUE


Kenvue Annual report: Q4 2025

Feb 17, 2026, 4:00 PM EST - 5 months ago

Kenvue Annual report: Q4 2025


Kenvue Earnings release: Q4 2025

Feb 17, 2026, 4:00 PM EST - 5 months ago

Kenvue Earnings release: Q4 2025


Kenvue Transcript: AGM 2026

Jan 29, 2026, 9:00 AM EST - 5 months ago

Kenvue Transcript: AGM 2026


Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

Jan 27, 2026, 6:40 AM EST - 6 months ago

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

KMB KVUE


Kenvue Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 7 months ago

Kenvue Proxy statement: Proxy Filing


Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Nov 6, 2025, 8:06 AM EST - 8 months ago

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

KVUE


Explainer: Is Tylenol safe to take during pregnancy?

Nov 3, 2025, 3:29 PM EST - 9 months ago

Explainer: Is Tylenol safe to take during pregnancy?

KMB KVUE


Suite510
Suite510 Jul. 15 at 5:01 PM
$JNJ $KVUE JNJ shares fall too, med tech earnings miss and huge Talc and Tylenol legal risks, that’s perfect medicine for them 🤣🙈
1 · Reply
Bazziggr
Bazziggr Jul. 14 at 7:58 PM
$KVUE moved to UTHR
0 · Reply
HydrogenH2
HydrogenH2 Jul. 14 at 3:14 PM
$DJT $KVUE $KMB Federal appeals court revives Tylenol autism lawsuits against Kenvue, overturning prior dismissal Ruling reopens potential for thousands of previously dismissed Tylenol autism cases against Kenvue. Court decision could expose Kenvue to billions of dollars in Tylenol-related autism liability claims.
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Jul. 14 at 3:09 PM
$KVUE back to 15 because of the banana republic legal system they installed.
0 · Reply
topstockalerts
topstockalerts Jul. 13 at 8:30 PM
Kenvue shares fell after Bloomberg reported that a U.S. federal appeals court revived lawsuits alleging the company concealed potential risks that Tylenol use during pregnancy could increase the likelihood of autism and other developmental disorders in children. A three-judge panel in New York ruled that the lower court abused its discretion by excluding testimony from three expert witnesses, sending the cases back for further proceedings, while agreeing that two other experts could remain excluded. The decision reverses a 2023 ruling that had prevented roughly 500 lawsuits from moving forward against Kenvue, the Johnson & Johnson consumer health spin-off. Plaintiffs claim the company failed to warn consumers about the alleged prenatal risks associated with the widely used over-the-counter pain reliever. $KVUE $JNJ
0 · Reply
MandelbrotMarkets
MandelbrotMarkets Jul. 13 at 8:22 PM
$KVUE is facing a new legal overhang. Shares dipped after a federal appeals court revived hundreds of lawsuits alleging Tylenol use during pregnancy may be linked to autism and ADHD risks. The company now faces renewed uncertainty around potential litigation costs and reputational impact. For investors, the key focus will be whether this becomes a material financial liability or remains a manageable legal headline.
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 13 at 8:00 PM
RECAP 7/13 Chatter: $KVUE $KMB - Tylenol Autism suit revived RECAP 7/13 +Pos Comments: $CEPL + BWS Financial $QTTB + Wells Fargo Live Breaking trading news www.openoutcrier.com
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 13 at 5:09 PM
KVUE Stock Dips After Court Revives Tylenol Autism Lawsuits $KVUE $JNJ $VTI $VOO https://stocktwits.com/news/equity/markets/kvue-stock-dips-after-court-revives-tylenol-autism-lawsuits/cZmzDliR7Yj
0 · Reply
LiveSquawk
LiveSquawk Jul. 13 at 3:22 PM
$KVUE | US Appeals Court Revives Lawsuits Against Kenvue; Kenvue Autism Risk Cases Sent Back To Lower Courts For Review
0 · Reply
Noxtradealerts
Noxtradealerts Jul. 13 at 2:31 PM
$0.31 on $KVUE here! 72% return!
0 · Reply
Blockwave1
Blockwave1 Jul. 13 at 2:28 PM
$0.31 on $KVUE here! 🌊72% return! 🔥
0 · Reply
Snipertradesexpert
Snipertradesexpert Jul. 13 at 2:28 PM
$0.31 on $KVUE here! 🧴 72% return!
0 · Reply
vonryan
vonryan Jul. 13 at 1:56 PM
$KVUE Slowly going up.
0 · Reply
Suite510
Suite510 Jul. 13 at 2:14 AM
$JNJ $KVUE Anyday now it’s hits the wall of reality
1 · Reply
Suite510
Suite510 Jul. 11 at 10:05 PM
$JNJ $KVUE oh look another 22M verdict plus the 45M verdict that’s 67M in only 2 days pay up lol 😂 Superior Court Nixes Bid For New Talc Trial Arising From $22M Verdict' On appeal, the plaintiffs argued that simply molding the verdict to reflect the jury's decision on causation wasn't enough to cure the inconsistency.
0 · Reply
Suite510
Suite510 Jul. 11 at 9:27 PM
$JNJ $KVUE And the hits just keep on coming 😂 Ill. Appeals Court Upholds $45M Talc Verdict Against J&J A split Illinois state appeals court on Friday refused to disturb a jury's verdict awarding $45 million to the family of a woman who developed mesothelioma and died after using Johnson & Johnson's talc baby powder for decades.
0 · Reply
topstockalerts
topstockalerts Jul. 10 at 8:50 PM
Kenvue saw elevated options activity on Friday, with 14,072 contracts traded by 18:01 ET, according to Bloomberg data. Calls dominated the session with 12,948 contracts, compared with 1,124 puts, signaling bullish positioning. The most actively traded contract was the July 17, 2026 $20 call, which generated 11,206 contracts versus 410 open interest at Thursday's close, suggesting fresh positions were being opened. Notable multi-leg activity included an August 7 put spread involving the $16 and $18 strikes, as well as an 800-contract diagonal call spread between the August 21, 2026 and February 19, 2027 expirations using the $19 and $20 strikes. Kenvue shares rose 1.93% to $19.55 during the session. Meanwhile, the company's three-month implied volatility fell 0.67 percentage points to 22.51%, while the three-month 90/110 skew edged down to 5.79%, indicating relatively stable options pricing despite the surge in trading activity. $KVUE
0 · Reply
Noxtradealerts
Noxtradealerts Jul. 10 at 3:03 PM
$KVUE 17 JUL 26 $20 CALL $0.18
0 · Reply
Blockwave1
Blockwave1 Jul. 10 at 2:55 PM
$KVUE🌊 17 JUL 26 $20 CALL $0.18 MONTHLY BULLISH OUTSIDE BAR + RELATIVE STRENGTH + PRICE UPGRADE BY RBC CAPITAL
0 · Reply
StockpeakHQ_1
StockpeakHQ_1 Jul. 10 at 2:54 PM
$KVUE 17 JUL 26 $20 CALL $0.18
0 · Reply
Snipertradesexpert
Snipertradesexpert Jul. 10 at 2:54 PM
$KVUE 17 JUL 26 $20 CALL $0.18
0 · Reply
liamsniperalert
liamsniperalert Jul. 10 at 2:54 PM
$KVUE 17 JUL 26 $20 CALL $0.18 MONTHLY BULLISH OUTSIDE BAR + RELATIVE STRENGTH + PRICE UPGRADE BY RBC CAPITAL
0 · Reply